This one-pager shows how Pfizer CentreOne supports your most complex OSD programs with specialized technologies, seamless process optimization and a proven right-first-time approach. 

From high-containment capabilities to 90–92% OTIF performance and global regulatory excellence, discover why innovators choose Pfizer CentreOne to manufacture their oral solid dose therapies reliably, at scale, and with the quality patients deserve.